Featured - 4 items
Rethink risk and compliance to drive strategy, capabilities and performance
Pharmaceutical and life sciences companies must consider a wide range of emerging risks as they adapt their business practices to changing regulatory compliance and market-driven pressures. Some of these include globalization, the advancement of technology and expanding stakeholder expectations. Risks are no longer confined to discrete areas and functions within organizations. From regulatory pressures to consumer demands for increased transparency, organizations are increasingly seeking total solutions. New information systems, strategies, and processes to manage compliance are rapidly evolving in response to these pressures.
Developing effective global tax strategies that address regulatory challenges and enable business success
Pharmaceutical and life sciences companies around the world are facing pressure to develop more effective tax strategies while remaining compliant in a constantly changing regulatory landscape. Tax concerns impact a wide range of areas that include research and development credits, transfer pricing, state and local planning, and more.
Contact us
Glenn Hunzinger
Health Industries Leader, PwC US
Rich Chirico
Partner, Tax Consulting Solutions Leader, PwC US
Laura Robinette
Health Industries Assurance Leader, Global Engagement Partner, PwC US
As the Health Industries Trust Solutions Leader, I’m guided by my passion for excellent service in helping our clients navigate complex problems across the sector.
Tim Canonico
Principal, Business Outcome Managed Services, PwC US
